Your latest news:
Interests in hearing insights on the pharmaceutical packaging supply chain? Access our on demand webinars here and sign up to access our next one!
Your latest news:
Interests in hearing insights on the pharmaceutical packaging supply chain? Access our on demand webinars here and sign up to access our next one!
Eli Lilly and Company’s latest findings on their anti-amyloid therapy, donanemab, have garnered optimism from the Alzheimer’s Drug Discovery Foundation
With just two weeks to go until Connect in Pharma 2023, we sat down with event co-founder Wilfried Phipps to discuss the many features and opportunities attendees can look forward to on 14th-15th June. Wilfried shares his insights into the key themes of the conference agenda and gives his advice about how you can make the most out of your visit.
The biopharmaceutical company Lexicon, have announced the approval of their drug INPEFA™ (sotagliflozin) by the FDA in effort to treatment
Connected health will be one of the topics discussed during the upcoming Connect in Pharma conferences. As experts in this sector, Eric Dessertenne, CEO of Biocorp, and Emre Ozcan, Global Head of Digital Health at Merck, will deliver talks on the challenges that lie ahead in the development of connected devices.
A select assortment of Bristol Myers Squibb’s medicines are headed into orbit where researchers will study the crystallization of the biotherapeutics in microgravity.
The global leader in medical technology, BD, has announced an advanced ultrasound device featuring a specialised probe aimed at facilitating
Insilico Medicine, a company that uses artificial intelligence (AI) for drug discovery and development, has integrated its AI-powered chatbot, “ChatPandaGPT,”
Scientists, Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D. from Shirley Ryan AbilityLab, and John Rogers, Ph.D. from Northwestern University,
Pfizer’s nasal spray, ZAVZPRET™, which treats migraines, has gained approval from the FDA. It is the first and only calcitonin
Travere Therapeutics, the biopharmaceutical company determined to develop treatment for people with rare diseases, have developed a drug called FILSPARI,
AstraZeneca’s main focus is in research and development, to work towards launching medicines that treat some of the most complex
Aptar Pharma is launching APF Futurity, its first metal-free, designed-for-recycling multidose nasal spray pump for nasal saline and other over-the-counter pharma
